Two Reviews Question Quality Of Cardiac PMA Trials

Two recent studies question the consistency and quality of clinical trials intended to support FDA premarket approvals of cardiac devices. As one of the studies was conducted by agency scientists, new requirements for PMA studies may soon be in the offing

More from Archive

More from Medtech Insight